Nasopharyngeal carcinoma

MLK Chua, JTS Wee, EP Hui, ATC Chan - The Lancet, 2016 - thelancet.com
Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from …

American Cancer Society head and neck cancer survivorship care guideline

EEW Cohen, SJ LaMonte, NL Erb… - CA: a cancer journal …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE The American Cancer Society Head and Neck
Cancer Survivorship Care Guideline was developed to assist primary care clinicians and …

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus

M Lambrecht, DBP Eekers, C Alapetite… - Radiotherapy and …, 2018 - Elsevier
Purpose For unbiased comparison of different radiation modalities and techniques,
consensus on delineation of radiation sensitive organs at risk (OARs) and on their dose …

Emerging treatment options for nasopharyngeal carcinoma

L Zhang, QY Chen, H Liu, LQ Tang… - … design, development and …, 2013 - Taylor & Francis
Nasopharyngeal carcinoma is endemic in Asia and is etiologically associated with Epstein–
Barr virus. Radiotherapy is the primary treatment modality. The role of systemic therapy has …

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

F Kong, J Zhou, C Du, X He, L Kong, C Hu, H Ying - BMC cancer, 2018 - Springer
Background To evaluate the effectiveness and toxicities of intensity-modulated radiotherapy
(IMRT) for locally recurrent nasopharyngeal carcinoma (NPC). Methods One hundred and …

Proton radiation therapy for head and neck cancer: a review of the clinical experience to date

EB Holliday, SJ Frank - … Journal of Radiation Oncology* Biology* Physics, 2014 - Elsevier
Proton beam radiation has been used for cancer treatment since the 1950s, but recent
increasing interest in this form of therapy and the construction of hospital-based and clinic …

Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center

LR Wu, YT Liu, N Jiang, YX Fan, J Wen, SF Huang… - Oral oncology, 2017 - Elsevier
Objectives Intensity-modulated radiotherapy (IMRT) has been applied in nasopharyngeal
carcinoma (NPC) for nearly twenty years, while little is known about the ten-year survival …

[HTML][HTML] Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new …

X Ou, X Zhou, Q Shi, X Xing, Y Yang, T Xu, C Shen… - Oncotarget, 2015 - ncbi.nlm.nih.gov
This study was to report the long-term outcomes and toxicities of nasopharyngeal carcinoma
(NPC) treated with intensity-modulated radiation therapy (IMRT). From 2009 to 2010, 869 …

The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin‐Induced Ototoxicity in Children With Cancer

JJ Yang, JYS Lim, J Huang, J Bass… - Clinical …, 2013 - Wiley Online Library
Ototoxicity is a debilitating side effect of platinating agents with substantial interpatient
variability. We sought to evaluate the association of thiopurine S‐methyltransferase (TPMT) …

[HTML][HTML] Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma

Y Ding, X Xiao, L Zeng, Q Shang, W Jiang, S Xiong… - Bioactive Materials, 2021 - Elsevier
Despite extensive use of radiotherapy in nasopharyngeal carcinoma (NPC) treatment
because of its high radiosensitivity, there have been huge challenges in further improving …